ArticleRedox biology2025

Cisplatin-induced genetic alterations in KEAP1 promote therapeutic resistance in head and neck squamous cell carcinoma.

Yuki Nakayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.